We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
-13.99%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$18.4B
AUM Growth
–
Cap. Flow
+$19.9B
Cap. Flow
% of AUM
108.64%
Top 10 Holdings %
Top 10 Hldgs %
28.05%
Holding
651
New
651
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GG
Goldcorp Inc
GG
|
+$1.05B |
| 2 |
B
Barrick Mining
B
|
+$803M |
| 3 |
Newmont
NEM
|
+$803M |
| 4 |
SLB Ltd
SLB
|
+$596M |
| 5 |
GOLD
Randgold Resources Ltd
GOLD
|
+$496M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 45.24% |
| 2 | Energy | 26.06% |
| 3 | Industrials | 5.86% |
| 4 | Consumer Staples | 4.48% |
| 5 | Healthcare | 2.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Pfizer
PFE
$144B
| $21.6M | 0.12% |
+811,286
| New | +$22.4M |
|
102
Biogen
BIIB
$30.9B
| $20.8M | 0.11% |
+96,715
| New | +$20.7M |
|
103
Goldgroup Mining Inc.
GORO
$148M
| $20.1M | 0.11% |
+2,313,036
| New | +$22.8M |
|
104
Exelon
EXC
$48.2B
| $20.1M | 0.11% |
+911,221
| New | +$22.1M |
|
|
CELG
105
DELISTED
Celgene Corp
CELG
| $19.9M | 0.11% |
+339,900
| New | +$20.5M |
|
|
GM.PRB
106
DELISTED
GENERAL MTRS CO JR PFD CONV SER B (DE)
GM.PRB
| $19.8M | 0.11% |
+411,663
| New | +$19.3M |
|
107
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.9B
| $19.8M | 0.11% |
+700,678
| New | +$19.4M |
|
108
iShares S&P 500 Value ETF
IVE
$49.4B
| $19.1M | 0.1% |
+252,427
| New | +$19.2M |
|
109
Tidewater
TDW
$3.61B
| $19M | 0.1% |
+10,365
| New | +$18.1M |
|
|
MXIM
110
DELISTED
Maxim Integrated Products
MXIM
| $19M | 0.1% |
+684,739
| New | +$20.8M |
|
111
Patterson-UTI
PTEN
$3.58B
| $19M | 0.1% |
+982,306
| New | +$21.4M |
|
112
Novartis
NVS
$301B
| $18.3M | 0.1% |
+288,400
| New | +$18.8M |
|
113
VEON
VEON
$3.48B
| $17.4M | 0.1% |
+69,343
| New | +$18.9M |
|
114
Andersons Inc
ANDE
$2.41B
| $17.4M | 0.09% |
+491,312
| New | +$17.4M |
|
115
Annaly Capital Management
NLY
$17.4B
| $17.2M | 0.09% |
+341,551
| New | +$20M |
|
116
Lindsay Corp
LNN
$1.13B
| $16.9M | 0.09% |
+225,256
| New | +$17.8M |
|
117
Texas Instruments
TXN
$251B
| $16.2M | 0.09% |
+463,918
| New | +$16.6M |
|
|
GSS
118
DELISTED
Golden Star Resources Ltd.
GSS
| $16M | 0.09% |
+7,628,915
| New | +$32.5M |
|
119
Merck
MRK
$324B
| $15.2M | 0.08% |
+343,401
| New | +$15.3M |
|
|
ALXN
120
DELISTED
Alexion Pharmaceuticals
ALXN
| $14.6M | 0.08% |
+157,918
| New | +$15.2M |
|
121
Illumina
ILMN
$29.1B
| $14.4M | 0.08% |
+197,818
| New | +$12.7M |
|
122
Vertex Pharmaceuticals
VRTX
$124B
| $14.4M | 0.08% |
+179,806
| New | +$13.2M |
|
123
Wolfspeed
WOLF
$1.07B
| $13.8M | 0.08% |
+215,926
| New | +$12.6M |
|
124
Regeneron Pharmaceuticals
REGN
$72.9B
| $13.7M | 0.07% |
+60,743
| New | +$14.1M |
|
|
MDR
125
DELISTED
McDermott International
MDR
| $13.5M | 0.07% |
+551,953
| New | +$16M |
|
Similar funds
DAM
VanEck Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for VanEck Associates, which disclosed 651 positions worth $18.4B. Its ten largest holdings account for 28% of the portfolio.
Its largest position is Goldcorp Inc: 37,142,019 shares worth $919M.
By sector, the portfolio is most concentrated in Materials at 45% of assets, followed by Energy and Industrials.
- VanEck Associates's largest Q2 2013 buy was Goldcorp Inc: 37,142,019 shares worth $919M.
- VanEck Associates's ten largest holdings make up 28% of its $18.4B portfolio in Q2 2013.
- VanEck Associates disclosed 651 positions in Q2 2013, its first 13F filing on record.
Based on VanEck Associates's 13F filing for Q2 2013, filed 14 Aug 2013.